Skip to main content

Table 3 Percentage of antibacterial resistance rates of Campylobacter species in Ethiopia, from 2004 to 2020

From: Prevalence of Campylobacter species in human, animal and food of animal origin and their antimicrobial susceptibility in Ethiopia: a systematic review and meta-analysis

Studies

Number of isolates

 

Antimicrobials resistance rate reported by 12 studies (%)

     

P

AMP

AML

E

STR

T

NA

CF

GM

CIP

CL

A/C

DC

NOR

CRO

T/S

CD

K

Lengerh et al. [13]

44

68.2

27.7

56.8

9.1

88.9

18.2

16

11.4

36.4

15.9

11.6

27.7

54.5

40.9

Beyene et al. [21]

50

50

10

14

0

0

60

0

Dadi et al. [10]

50

10

6

2

20

10

14

4

12

Kebede et al. [27]

13

23.1

23.1

7.7

0

7.7

53.8

0

0

61.5

Getamesay et al. [28]

20

30

80

55

15

20

70

70

10

0

0

20

Chanyalew et al. [25]

48

33.3

4.2

20.8

2.1

100

Tafa et al. [24]

38

76

18.4

39.5

10.5

100

13.2

15.8

31.6

23.7

10.5

68.4

26.3

Ewnetu et al. [11]

15

18.8

18.8

25

22.2

12.5

160

34.1

14.9

20.5

30.1

Kassa et al. [22]

192

19.8

2.6

6.3

2.6

6.3

96.9

0.5

2.2

38.5

2.1

Abamecha et al. [29]

208

38.9

50.5

69.2

3.8

100

71.2

51.4

54.3

45.7

Nigatu et al. [26]

84

100

8.3

60

13.1

35.7

0

40.5

  1. AMP Ampicillin, AML Amoxicillin, E Erythromycin, STR Streptomycin, T Tetracycline, NA Nalidixic acid, P Penicillin, CF Cephalothin, GM Gentamicin, CIP Ciprofloxacin, CL Chloramphenicol, A/CAmoxicillin with clavulanic acid, DC Doxycycline, NOR Norfloxacin, CRO Ceftriaxone, T/S Trimethoprim-sulfamethoxazole, CD Clindamycin, K Kanamycin